Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2018 impact factor is 8.402. Molecular Therapy — Methods & Clinical Developments The aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella. Molecular Therapy – Methods & Clinical Development's 2018 impact factor is 4.875.
《分子疗法》 是有关基因转移，载体开发和设计，干细胞操纵，基于基因，肽，蛋白质，寡核苷酸和基于细胞的疗法开发的研究领域的领先期刊，以纠正遗传性和后天性疾病，疫苗开发，临床前靶标验证，安全性/功效研究和临床试验。分子疗法 致力于促进遗传学，医学和生物技术领域的科学发展。该刊发表重要的同行评审研究以及前沿的评论和评论，继续吸引该领域的最佳材料。 分子疗法的 2018影响因子是8.402。 分子疗法—方法与临床发展 的目的 分子疗法的方法与临床发展 是建立在成功分子疗法 在出版重要同行评审的方法和程序，以及翻译的进步领域的分子治疗伞下的广泛阵列英寸 分子疗法–方法与临床发展的 2018影响因子是4.875。。